For the Inventor, By the Inventor

Enter inventor name

Rehovot, Israel

David Wallach

USPTO Granted Patents = 66 (Patent Applications = 2)

EPO Patents = 16 (Patent Applications = 5)

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 541(Granted Patents)

Forward Citations (Not Self Cited) = 530(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Holon, IL (1977)
Rehovot, IL (1981 - 2013)

Company Filing History:

60 out of 1,168

Yeda Research and Develpment & Co. Ltd

The Weizmann Institute of Science

Ben-gurion University of the Negev Research and Development Authority

4. 1 out of 169

Hadasit Medical Research Services and Development Ltd.

Yeda Research and Development Ltd.

6. 3 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1977-2013

Loading Chart...

Loading Chart...

Areas of Expertise:

Anti-NIK Antibodies

Chimeric Proteins

Pharmaceutical Compositions

Caspase-8

TNF Receptor Modulation

NF-kB Inducing Enzyme

IL-2 Receptor Derivatives

FAS Receptor Modulators

SIVA Protein

Cytocidal Effect Inhibition

Tumor Necrosis Factor

Regulatory Protein Antibodies

66 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8383781 - Anti-NIK antibodies and uses thereof (2013-02-26),

2. 8377433 - SIVA 3, its preparation and use (2013-02-19),

3. 8362206 - Chimeric proteins and uses thereof (2013-01-29),

4. 8338567 - Pharmaceutical compositions for treating diseases associated with NF-κB activity (2012-12-25),

5. 8330026 - Derivatives of the NF-κB inducing enzyme, their preparation and use (2012-12-11),

6. 8318660 - Method of treating a disease by administering caspase-8 (2012-11-27),

7. 8304384 - Caspase-8 and inflammation, infection and wound healing (2012-11-06),

8. 8273545 - SIVA ubiquitination and/or degradation-related activity and modulators thereof (2012-09-25),

9. 8236507 - Modulators of TNF receptor associated factor (TRAF), their preparation and use (2012-08-07),

10. 8138323 - Isolated cDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA (2012-03-20),

11. 8092806 - Chimeric proteins, their preparation and pharmaceutical compositions containing them (2012-01-10),

12. 8048847 - Derivatives of the IL-2 receptor gamma chain, their production and use (2011-11-01),

13. 8034340 - Method for treating an immune disorder by decreasing NIK-SIVA complex formation (2011-10-11),

14. 7799901 - Modulators of the function of FAS receptors and other proteins (2010-09-21),

15. 7745579 - Inhibitor of NF-KB activation (2010-06-29),

Title: The Innovative Journey of David Wallach

Introduction: David Wallach, a pioneering inventor hailing from Rehovot, Israel, has made significant contributions to the field of technology and innovation.

Latest Patents: David Wallach holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his illustrious career, David Wallach has been recognized for his groundbreaking inventions that have revolutionized various industries. His commitment to pushing the boundaries of innovation has led to the development of cutting-edge solutions that address complex challenges.

Collaborations: David Wallach has collaborated with leading research institutions, universities, and tech companies to further his inventions and bring them to market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, David Wallach's passion for innovation, coupled with his technical acumen, has solidified his reputation as a trailblazing inventor in the global technology landscape. His relentless pursuit of excellence continues to inspire future generations of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…